Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,045 | 32,306 | 35,898 | 42,854 | 29,117 |
| Marketable Securities | 24,385 | 38,941 | 50,512 | 52,365 | 65,855 |
| Receivables | 14,610 | 12,835 | 18,885 | 19,643 | 25,457 |
| Inventories | 20,114 | 20,838 | 18,180 | 19,570 | 17,924 |
| TOTAL | $96,671 | $108,087 | $127,044 | $137,804 | $144,095 |
| Non-Current Assets | |||||
| PPE Net | 16,525 | 17,305 | 16,816 | 15,370 | 15,258 |
| Investments And Advances | 0 | 0 | 0 | 0 | 6,493 |
| Intangibles | 183,908 | 186,751 | 189,553 | 192,354 | 195,108 |
| Other Non-Current Assets | 9,291 | 8,278 | 8,621 | 8,907 | 9,096 |
| TOTAL | $209,724 | $212,334 | $214,990 | $216,631 | $225,955 |
| Total Assets | $306,395 | $320,421 | $342,034 | $354,435 | $370,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,967 | 4,871 | 5,830 | 4,439 | 6,094 |
| Accrued Expenses | 3,996 | 2,972 | 3,335 | 5,420 | 3,553 |
| TOTAL | $29,500 | $27,915 | $32,315 | $30,520 | $30,081 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,163 | 9,724 | 9,028 | 9,101 | 9,419 |
| Other Non-Current Liabilities | 198,207 | 198,871 | 198,606 | 197,186 | 197,075 |
| TOTAL | $223,662 | $224,534 | $225,455 | $224,938 | $225,068 |
| Total Liabilities | $253,162 | $252,449 | $257,770 | $255,458 | $255,149 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,208 | 29,118 | 29,037 | 28,897 | 28,844 |
| Common Shares | 29 | 29 | 29 | 29 | 29 |
| Retained earnings | -439,477 | -421,781 | -401,993 | -383,375 | -363,492 |
| Other shareholders' equity | -760 | -911 | -858 | -885 | -1,144 |
| TOTAL | $53,233 | $67,972 | $84,264 | $98,977 | $114,901 |
| Total Liabilities And Equity | $306,395 | $320,421 | $342,034 | $354,435 | $370,050 |